Can methotrexate cause lung problems?
Yes. Methotrexate can cause lung injury, including drug-induced pneumonitis (often called “methotrexate lung”). This is one of the more serious methotrexate side effects and can affect people using the medication for cancer or autoimmune diseases. Patients are typically advised to report new or worsening breathing symptoms promptly.
Key symptoms that raise concern include a new dry cough, shortness of breath, fever, and chest discomfort.
What does methotrexate pneumonitis feel like—and how is it different from an infection?
Methotrexate pneumonitis can look like infection because symptoms overlap (cough, fever, breathing difficulty). Clinicians often use the context of symptoms timing, exam findings, imaging (like chest X-ray or CT), and lab work to distinguish drug toxicity from pneumonia. Because both can be dangerous, worsening breathing symptoms while on methotrexate should be treated as urgent medical issues until proven otherwise.
When do lung symptoms typically show up after starting methotrexate?
Lung toxicity can occur at different times after starting methotrexate. It can appear after weeks to months, and sometimes later with ongoing therapy. The risk is not limited to early treatment, so new respiratory symptoms at any point warrant evaluation.
Who is at higher risk for methotrexate lung disease?
Risk is influenced by factors such as:
- Higher methotrexate dose and certain dosing schedules
- Prior lung disease
- Age and overall health status
- Concomitant medications that can also affect the lungs
- Prior chest radiation (in some settings)
- Possible contribution from folate deficiency and other general risk factors
Because the exact risk profile varies by patient and indication, clinicians generally monitor closely and counsel patients on symptom reporting.
What should you do if you develop cough or shortness of breath on methotrexate?
Seek prompt medical care. Do not stop methotrexate on your own unless a clinician tells you to. Clinicians may stop or hold the medication and evaluate you for pneumonitis versus infection or other causes. Treatment, when methotrexate pneumonitis is suspected, often involves stopping methotrexate and using medications such as corticosteroids, depending on severity and the diagnostic workup.
What tests are used to evaluate “methotrexate and lungs” concerns?
Common evaluation steps include:
- Chest imaging (X-ray and sometimes CT)
- Pulse oximetry and oxygen assessment
- Blood tests (to support inflammation and help rule out infection)
- Sometimes tests to rule out other causes such as blood clots or other lung diseases
- Medication review and timing relative to symptom onset
Can methotrexate lung problems be prevented?
Prevention focuses on early detection and risk reduction:
- Take methotrexate exactly as prescribed
- Report new respiratory symptoms quickly
- Attend monitoring visits and follow clinician instructions about labs and follow-up
- Discuss risk factors (like existing lung disease or prior radiation) with the prescriber
What happens if methotrexate lung disease is treated late?
Delayed treatment can increase the chance of more severe lung injury and longer recovery. That’s why new or worsening breathing symptoms during methotrexate therapy are treated as urgent.
Does methotrexate affect oxygen levels and breathing long-term?
Some people recover after treatment changes, but severity varies. In more serious cases, lung damage can lead to prolonged symptoms. This is another reason early evaluation matters.
How do folic acid or folinic acid relate to methotrexate lung risk?
Folate supplementation is routinely used with methotrexate to reduce certain toxicities. Whether and how much it changes the risk of lung injury is not straightforward, but folate is part of standard methotrexate safety management for many patients. Follow your prescriber’s folate instructions.
Is methotrexate lung toxicity the same as “pulmonary fibrosis”?
Methotrexate pneumonitis and pulmonary fibrosis are related but not identical. Pneumonitis is an inflammatory lung reaction; fibrosis is scarring that can occur in some inflammatory lung conditions. Clinicians evaluate to determine whether symptoms reflect acute inflammation, chronic scarring, or another process.
---
If you tell me the context (are you asking as a patient on methotrexate for rheumatoid arthritis/psoriasis/IBD or for cancer? your dose, how long you’ve been on it, and your symptoms), I can help narrow what to ask your doctor and what evaluation usually happens next.